A single-institution retrospective study of comprehensive genomic profiling tests based on C-CAT findings for advanced solid cancers
In conclusion, comprehensive genomic profiling tests have the potential to be valuable in identifying genomic abnormalities. Even if there is no effective treatment at present, it may lead to a treatment in the future. Comprehensive genomic profiling tests should be considered for any cancer.
Authors
- Masahiko Kuroda (ORCID: https://orcid.org/0000-0001-7052-4289)
- Aoi Sukeda
- Atsushi Sofuni (ORCID: https://orcid.org/0000-0002-5417-6752)
- Toshitaka Nagao (ORCID: https://orcid.org/0000-0003-2075-9738)
- Tomohiro Umezu (ORCID: https://orcid.org/0000-0002-0123-8921)
- N. Inagaki (ORCID: https://orcid.org/0000-0003-4305-1863)
- Masahiro Seike (ORCID: https://orcid.org/0000-0002-1572-5472)
- Susumu Takeuchi (ORCID: https://orcid.org/0000-0002-0617-0962)
- Masato Bingo (ORCID: https://orcid.org/0000-0001-8716-8890)
- Yuri Ueda (ORCID: https://orcid.org/0000-0001-8594-9909)
- Jun Matsubayashi (ORCID: https://orcid.org/0000-0001-7545-9332)
- Tatsuo Ohira (ORCID: https://orcid.org/0000-0002-7927-6987)
- Norihiko Ikeda (ORCID: https://orcid.org/0000-0002-5141-8808)
- Akinobu Yoshimura
Institutions
- Tokyo Medical University (JP)
- Tokyo Medical University Hospital (JP)
- Nippon Medical School (JP)
Publication Details
- Journal
- Japanese Journal of Clinical Oncology
- Published
- 2024-09-19
- DOI
- https://doi.org/10.1093/jjco/hyae128
- Citations
- 1
- Primary Topic
- Cancer Genomics and Diagnostics
- Type
- article
- Field-Weighted Citation Impact
- 0.29